The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 25, 2025
Filed:
May. 24, 2023
Applicant:
Blue Goji Llc, Austin, TX (US);
Inventor:
Coleman Fung, Austin, TX (US);
Assignee:
BLUE GOJI LLC, Austin, TX (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A63B 24/00 (2006.01); A63B 22/00 (2006.01); A63B 22/02 (2006.01); A63B 22/06 (2006.01); A63B 23/04 (2006.01); A63F 13/212 (2014.01); A63F 13/214 (2014.01); A63F 13/40 (2014.01); A63F 13/65 (2014.01); G06F 1/16 (2006.01); G06F 3/01 (2006.01); G06T 19/00 (2011.01); H04W 84/18 (2009.01);
U.S. Cl.
CPC ...
A63B 24/0003 (2013.01); A63B 22/0046 (2013.01); A63B 22/0285 (2013.01); A63B 22/0292 (2015.10); A63B 22/06 (2013.01); A63B 23/04 (2013.01); A63F 13/212 (2014.09); A63F 13/214 (2014.09); A63F 13/40 (2014.09); A63F 13/65 (2014.09); G06F 1/163 (2013.01); G06F 3/011 (2013.01); G06F 3/016 (2013.01); G06T 19/006 (2013.01); H04W 84/18 (2013.01);
Abstract
A system and method for targeted neurological therapy using a primary task and a plurality of associative activities, wherein the associative activities provide social engagement as a therapeutic element. The system and method receive various biometric data associated with an individual performing a multiple-task stimulation therapy regimen, computes a performance score for the individual, and makes adjustments to the therapy regimen based on the performance score. In some implementations, the system is supported by one or more machine learning predictive models configured to generate therapy regimen adjustment recommendations.